No Aspirin Needed After LVAD, ARIES-HM3 Trial Says
PHILADELPHIA — Dropping aspirin from the antithrombotic regimen after HeartMate 3 left ventricular assist device (LVAD) implantation appeared safer than the usual combination approach in the ARIES-HM3 trial. Atop warfarin or other vitamin K antagonist therapy, placebo was noninferior to low-dose aspirin for the primary composite endpoint of survival free of stroke, pump thrombosis, major […]